FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
We have now added a new section called the "Assay History List" to the "At A Gla...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...